Fig. 4
From: Comparison of charges and resource use associated with saxagliptin and sitagliptin

Inpatient hospitalization rates during the follow-up period: after propensity matching
From: Comparison of charges and resource use associated with saxagliptin and sitagliptin
Inpatient hospitalization rates during the follow-up period: after propensity matching